Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

Clinical trial NCT05469893 · RECRUITING

Trial details

NCT number: NCT05469893
Sponsor: Irene Ghobrial, MD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

High-risk Smoldering Multiple Myeloma Smoldering Multiple Myeloma Multiple Myeloma

Start date: 2022-08-10
Primary completion: 2030-07-31
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.